Home / Research Library / Gastric Cancer, Version 2.2022, NCCN Clinical Prac...
🧬 Medicine & Biology OpenAlex

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

📅 February 1, 2022 👤 Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem et al. 📖 Journal of the National Comprehensive Cancer Network 📊 1,695 citations

🤖 Plain-English Summary

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Multidisciplinary team management is essential for all patients with localized gastric cancer.

🔑 Key Findings

  • Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type.
  • Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage.
  • Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Feb 01, 2022
Journal Journal of the National Comprehensive Cancer Network
Authors Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem, Joseph Chao, David T. Cooke
DOI 10.6004/jnccn.2022.0008
Citations 1,695
Source OpenAlex

More 🧬 Medicine & Biology Research